Home › Funds › Boxer Capital Management, LLC › URGN

Boxer Capital Management, LLC position in URGN

UROGEN PHARMA LTD COM · Health Care

Boxer Capital Management, LLC reported holding 500,000 shares of URGN (UROGEN PHARMA LTD COM) in its Q2 2026 13F filing — a position valued at US$18.4M, representing 1.39% of its reported portfolio and ranking #18 among its reported holdings. Boxer Capital Management, LLC has disclosed URGN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)500.00K sh
Reported value held$18.40M
Portfolio Weight1.39%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's URGN position evolved

Boxer Capital Management, LLC first disclosed a stake in URGN in Q2 2025 at 575,000 shares (US$7.9M). The position peaked in Q2 2026 at 500,000 shares, worth US$18.4M. Across 5 filings, Boxer Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 500,000 shares valued at US$18.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 575.00K $7.88M New
Q3 2025 575.00K $11.47M Hold
Q4 2025 500.00K $11.71M Reduce
Q1 2026 500.00K $8.99M Hold
Q2 2026 500.00K $18.40M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About URGN and 13F data

URGN (UROGEN PHARMA LTD COM) is a Health Care company. 39 other funds we track also report a position in URGN — the largest reported positions include RTW INVESTMENTS, LP (US$167.2M), Kynam Capital Management, LP (US$89.6M), Jefferies Financial Group Inc. (US$80.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding URGN

All URGN fund holders →

FAQ

How long has Boxer Capital Management, LLC held URGN?

Boxer Capital Management, LLC has disclosed URGN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Boxer Capital Management, LLC's current position in URGN?

As of Q2 2026, Boxer Capital Management, LLC holds 500.00K shares of URGN (UROGEN PHARMA LTD COM), valued at $18.40M, representing 1.39% of its reported portfolio and ranking #18.

Has Boxer Capital Management, LLC been buying or selling URGN?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in URGN. The position peaked in Q2 2026 at 500.00K shares.

Which other funds hold URGN?

Other major institutional holders of URGN include RTW INVESTMENTS, LP, Kynam Capital Management, LP, Jefferies Financial Group Inc., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.